Skip to main content
. 2019 Nov 1;10(27):6848–6857. doi: 10.7150/jca.36614

Figure 3.

Figure 3

cAMP can modulate DNA damage, DNA repair and cell apoptosis to affect cellular survival or prognosis of patients with lung cancer. It can regulate the sensitivity to radiotherapy and chemotherapy in lung cancer patients, through the modulation of these three popular effectors: Bcl-2, IAPs and XRCC1. Given that these modulation of the three elements, cAMP can play an important role in the control of DNA damage and cell apoptosis. And then have an effect on the drug-resistance in lung cancer patients.